Therapeutic Drug Monitoring of 5-Fluorouracil in Head and Neck Cancer Patients: An Interventional Pilot Study
Introduction 5-fluorouracil (5-FU) is a crucial agent in treating various types of cancer, particularly recurrent head and neck cancers (HNCs). According to prior studies, individuals who underwent therapeutic drug monitoring (TDM) based 5-FU dosage adjustments showed significantly higher...
Saved in:
| Main Authors: | P. Sharmila Nirojini, N.K. Bhuvaneshwari, N. Dharsshini, S. Dhivya Bharathi, K. Velavan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2024-04-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1776294 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Monoclonal Antibodies as Therapeutics in HPV-Related Head and Neck Cancers: An Updated Review
by: Michael Zalin, et al.
Published: (2025-04-01) -
Melioidosis in the head-and-neck region
by: Santosh Kumar Swain, et al.
Published: (2024-11-01) -
Head and neck reconstruction
by: Prabha Yadav
Published: (2013-05-01) -
From the history of development of departments of medical service for head and neck tumors
by: P. V. Svetitsky, et al.
Published: (2024-04-01) -
Therapeutic role of selective preoperative embolization in patients with paraganglomas of head and neck
by: Sekulić Igor, et al.
Published: (2021-01-01)